A model-based approach for assessing in vivo combination therapy interactions

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 23, 1999, Pages 13023-13028

  Lopez, Angela M ^a   Pegram, Mark D ^a   Slamon, Dennis J ^a   Landaw, Elliot M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; MONOCLONAL ANTIBODY;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; STATISTICAL MODEL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0033539525     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.23.13023     Document Type: Article

References (15)

1. Heitjan, D. F., Manni, A. & Santen, R. J. (1993) Cancer Res. 53, 6042-6050.
2. Heitjan, D. F. (1991) Stat. Med. 10, 1075-1088.
3. Bliss, C. I. (1993) Ann. Appl. Biol. 26, 585-615.
4. Greco, W. R., Bravo, G. & Parsons, J. C. (1995) Pharm. Rev. 47, 331-385.
5. Loewe, S. (1953) Arzneimittelforsch. 3, 285-320.
6. Webb, J. L. (1963) Enzyme and Metabolic Inhibitors (Academic, New York), Vol. 1, pp. 55-79, 488-512.
7. Chou, T.-C. & Talalay, P. (1984) Adv. Enz. Reg. 22, 27-55.
8. Pietras, R. J., Fendly, B. M., Chazin, V. R., Pegram, M. D., Howell, S. B. & Slamon, D. J. (1994) Oncogene 9, 1829-1838.
9. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A. & McGuire, W. L. (1987) Science 235, 177-182.
10. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. & Ullrich, A. (1989) Science 244, 707-712.
11. Wheldon, T. E. (1988) Mathematical Models in Cancer Research (Adam Hilger, Bristol), pp. 63-90.
12. Dixon, W. J., ed. (1992) BMDP Statistical Software Manual Vol. 1, (Univ. of California Press, Los Angeles), pp. 427-455.
13. Steimer, J.-L., Mallet, A., Golmard, J.-L. & Boisvieux, J.-F. (1984) Drug Met. Rev. 15, 265-292.
14. Racine-Poon, A. & Smith, A. F. (1990) in Statistical Methodology in the Pharmaceutical Sciences, ed. Berry, D. A. (Marcel Dekker, New York), pp. 139-162.
15. Littell, R. C. & Folks, J. L. (1971) JASA 66, 802-806.